Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1408537 | 0.86 | CYP3A4 (0.56) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| SCHEMBL15753141 | 0.84 | CYP3A4 (0.44) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| SCHEMBL28106819 | 0.82 | ALDH1A1 (0.75) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| SCHEMBL48239 | 0.82 | ALDH1A1 (0.75) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| SCHEMBL15762203 | 0.81 | LTA4H (0.52) | SMN1; SMN2ALDH1A1GAAMEN1LMNA | |
| SCHEMBL12052125 | 0.81 | LTA4H (0.53) | CYP3A4GAACYP19A1 | |
| Alcohol SCHEMBL28244815 | 0.80 | PPARA (0.44) | CYP3A4SMN1; SMN2PPARAMEN1LMNA | |
| Ethylene Glycol SCHEMBL11119213 | 0.79 | ALDH1A1 (0.71) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| Water SCHEMBL29229746 | 0.79 | ALDH1A1 (0.71) | CYP3A4SMN1; SMN2ALDH1A1RECQLNR1I2 | |
| SCHEMBL2970086 | 0.79 | KDM4E (0.41) | CYP3A4SMN1; SMN2ALDH1A1GAAMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9102673-B2 | Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-08-11 | — | — | US | disclosed |
| US-9102673-B2 | Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-08-11 | — | — | US | disclosed |
| US-9102673-B2 | Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-08-11 | — | — | US | disclosed |
| US-20140155413-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. | 2014-06-05 | — | — | US | disclosed |
| US-20140155413-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. | 2014-06-05 | — | — | US | disclosed |
| US-20140155413-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. | 2014-06-05 | — | — | US | disclosed |
| WO-2013009582-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. (US) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155413-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | NGF, NGFR, NTRK2 | CYP3A4 4420/4885SMN1; SMN2 2119/4885ALDH1A1 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.